Veuillez visiter la page anglaise pour plus de détails.
- CX5 Low-risk Early Stage Cervical Cancer (SHAPE)
- REGN2810 Recurrent or Metastatic Platinum-Refractory Cervical Cancer
- CR1525MK Advance Solid Tumor: Pembrolizumab
- CA209-484 Solid Tumors of High Tumor Mutational Burden (TMB-H) Nivolumab +/- Ipilimumab
- CAPTUR (Canadian Profiling and Targeted Agent Utilization Trial)